AARTI PHARMALABS
Back to All Ratios
|
AARTI PHARMALABS Last 5 Year EBIT Margin History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
EBIT Margin(%) | 17.15 | 14.49 | 13.95 | - |
What is the latest EBIT Margin ratio of AARTI PHARMALABS ?
Year | EBIT Margin |
---|---|
Mar2024 | 17.15 |
Mar2023 | 14.49 |
Mar2022 | 13.95 |
Mar2021 | - |
How is EBIT Margin of AARTI PHARMALABS Trending?
Years | EBIT Margin | % Change | |
---|---|---|---|
Mar2024 | 17.15 | 18.36 | |
Mar2023 | 14.49 | 3.87 | |
Mar2022 | 13.95 | 0 | |
Mar2021 | 0 | - |
Other Financial Ratios of AARTI PHARMALABS
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Margin ratio of peers of AARTI PHARMALABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI PHARMALABS | ₹6,309.8 Cr | -7% | -4.5% | 74.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
AARTI PHARMALABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI PHARMALABS | -7% |
-4.5% |
74.1% |
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses